UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other ...

Financial and other terms of the deal were not disclosed.

The program offers lower-cost, refurbished testing instruments as well as customer education, inventory management, and enhanced service agreements.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The all-virtual program is currently looking for a second cohort of novel diagnostics technologies, with a Sept. 30 deadline for new applications.

WASHINGTON – In a presentation this week at the Next Generation Dx conference here, the National Cancer Institute's Wendy Rubinstein gave an update on the NCI's Vanguard study of multi-cancer early ...

NEW YORK – AdvaMed, along with 66 other stakeholder groups, sent a letter to US Centers for Medicare and Medicaid Services Administrator Mehmet Oz on Wednesday urging the agency to create a pathway ...

According to a company executive, the transactions will provide QuidelOrtho with greater financial flexibility while funding its continued growth.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...

NEW YORK – Agilent Technologies said Wednesday that it has received US Food and Drug Administration approval for a companion diagnostic test to inform the treatment of patients with mismatch repair ...